OrthoNorCal Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • OrthoNorCal's estimated annual revenue is currently $6.7M per year.(i)
  • OrthoNorCal's estimated revenue per employee is $216,000

Employee Data

  • OrthoNorCal has 31 Employees.(i)
  • OrthoNorCal grew their employee count by -9% last year.

OrthoNorCal's People

NameTitleEmail/Phone
1
Orthopedic Spine SurgeonReveal Email/Phone
2
Athletic TrainerReveal Email/Phone
3
physicianReveal Email/Phone
4
doctorReveal Email/Phone
5
doctorReveal Email/Phone
6
doctorReveal Email/Phone
7
doctorReveal Email/Phone
8
doctorReveal Email/Phone
9
Surgery SchedulerReveal Email/Phone
10
Scheduling LeadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.7M5-81%N/AN/A
#2
$17M70-4%N/AN/A
#3
$4.9M264%N/AN/A
#4
$10.2M4718%N/AN/A
#5
$0.7M5-92%N/AN/A
#6
$66.2M2239%N/AN/A
#7
$12.6M5227%N/AN/A
#8
$53.2M179-2%N/AN/A
#9
$5.1M27-10%N/AN/A
#10
$22.1M824%N/AN/A
Add Company

What Is OrthoNorCal?

OrthoNorCal is a group of orthopedic doctors offering full-service comprehensive bone, joint, and muscle care with four state-of-the-art facilities across Silicon Valley and the South Bay region. We offer both surgical and non-surgical solutions for all areas of the body including sports medicine, total joint replacement, pediatric orthopedics, orthopedic trauma, fracture management, foot & ankle, elbow, hand, hip, knee, shoulder, spine, imaging, and workers’ compensation/occupational health. Our goal in creating a leading orthopedic group like OrthoNorCal is to continue our mission in providing you with the highest level of care and compassion you deserve in a personalized setting, while helping to get you back to what’s most important to you.

keywords:N/A

N/A

Total Funding

31

Number of Employees

$6.7M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.7M3214%N/A
#2
$3.7M32N/AN/A
#3
N/A336%N/A
#4
$4M336%N/A
#5
$6.4M34-21%N/A